Abstract: The present invention relates to a anti-proliferative target for designing chemotherapeutic agents, which comprises a EIF4A protein having an amino acid sequence, as defined in claim 1.
Type:
Grant
Filed:
July 24, 2006
Date of Patent:
August 30, 2011
Assignee:
The Royal University for the Advancement of Learning/McGill University
Inventors:
Jerry Pelletier, Marie-Ève Bordeleau, Lisa Lindqvist, Robert Francis, Junichi Tanaka